Published in Blood Weekly, March 22nd, 2001
Because one function of IL-10 is to protect cells from apoptosis induced by steroids or doxorubicin, and malignant Hodgkin cells have IL-10 receptors, Theodoros P. Vassilakopoulos and colleagues suspected that the cytokine may have a protective effect on these cancerous cells.
After studying more than 120 Hodgkin's patients who had been "treated with ABVD or equivalent regimens with or without radiotherapy," they appear to have to been proved correct. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.